Effects of recombinant human growth hormone in juvenile nile crocodiles (Crocodylus niloticus)

dc.contributor.author	Kanui, Titus I.
dc.contributor.author	Andersen, Øivind
dc.contributor.author	Kimwele, Charles
dc.contributor.author	Aulie, Arnfinn
dc.date.accessioned	2015-01-20T11:46:01Z
dc.date.available	2015-01-20T11:46:01Z
dc.date.issued	1990
dc.identifier.citation	Comparative Biochemistry and Physiology Part A: Physiology Volume 97, Issue 4, 1990, Pages 607–609	en_US
dc.identifier.uri	http://www.sciencedirect.com/science/article/pii/030096299090135F
dc.identifier.uri	http://hdl.handle.net/123456789/654
dc.description.abstract	1. Recombinant human growth hormone (hGH) showed somatotropic activity in juvenile Nile crocodiles (Crocodylus niloticus). 2. Body weight of crocodiles receiving 3.25 μg hGH/g body weight twice a week was increased by 49% after five weeks of treatment, compared to 31% increase in controls. 3. Total length was increased by 15 and 5%, respectively, in the two groups. 4. Food conversion efficiency increased from 28% in the controls to 36% in the hormone injected animals. 5. Cessation of hormone treatment was followed by reduced appetite and decreasing body growth.	en_US
dc.language.iso	en	en_US
dc.publisher	Elsevier	en_US
dc.title	Effects of recombinant human growth hormone in juvenile nile crocodiles (Crocodylus niloticus)	en_US
dc.type	Article	en_US